From the 25th to the 26th, the "2023 China Biopharmaceutical Enterprises Top 100 Innovative Series List" and "2023 China Pharmaceutical Industry Top 100 Series List" were announced, which attracted much attention from the pharmaceutical industry. Lunan Pharmaceutical Group ranked 12th in the "Top 10 BigPharma Enterprises in China in Innovation" and the "Top 100 Chinese Chemical Pharmaceutical Enterprises in 2023"!
The selection of the "2023 China Top 100 Biopharmaceutical Enterprises in Innovation Series List" is based on the Ministry of Science and Technology's "Enterprise Innovation Ability Evaluation Index System" as the theoretical basis, according to the four dimensions and 11 index systems of innovation evaluation indicators "innovation investment", "innovation achievements", "intellectual property rights" and "innovation driven", combined with the annual reports of innovative drug companies, CDE review data, third-party patent statistical agencies and public data statistics, and the results of the list are obtained by conducting a comprehensive evaluation of innovative drug companies.
The "2023 China Top 100 Pharmaceutical Industry Series List" is divided into five series of lists: "Top 100 Chinese Chemical Pharmaceutical Enterprises", "Top 100 Chinese Medicine Enterprises", "Top 20 Chinese CXO Enterprises", "Top 20 Chinese Medical Device (including IVD) Enterprises" and "Top 20 Chinese Biopharmaceutical (including Blood Products, Vaccines, Insulin, etc.) Enterprises".
Attached is the list of "Top 100 Chinese Chemical Pharmaceutical Enterprises in 2023":
As a comprehensive pharmaceutical group integrating the production, scientific research and sales of medicines, chemicals and biological products, Lunan Pharmaceutical has always adhered to the concept of "Lunan Pharmaceutical Healthy World" and focused on the cause of national health. In the future, the company will continue to help empower brands in the field of big health through quality adherence, technological innovation and service innovation, build a new ecology for the development of the pharmaceutical industry, and benefit more patients.
Source: Lunan Pharmaceutical Group WeChat public account
Editor: Little W